Krill Oil 500 mg - 60 Softgels

Neptune Krill Oil (NKO®) — 1,000 mg Softgels, 60 ct — Supports Triglycerides, Joint, Eye & Cognitive Health*

LifeSource Vitamins Neptune Krill Oil provides 1,000 mg of Antarctic krill oil (NKO®) per serving, supplying omega-3 EPA & DHA predominantly in phospholipid form plus naturally occurring astaxanthin. NKO® is produced by Aker BioMarine; their Antarctic krill fishery is MSC-certified for sustainability. Made in FDA-registered, GMP-certified facilities and 3rd-party tested for identity, potency, and purity.*

• Helps lower fasting triglycerides (borderline-high/high)* — 12-week RCT in adults with TG 150–499 mg/dL (NIH/PubMed — Ulven SM, 2014).
• Supports lipid management* — Meta-analysis reported significant TG reductions vs control (NIH/PubMed — Cicero AFG, 2020).
• Supports very high triglyceride management* — Krill-derived omega-3s lowered TG in severe hypertriglyceridemia contexts (NIH/PubMed — Skulas-Ray AC, 2022).
• Supports endothelial function (type 2 diabetes)* — RCT noted vascular function/HDL signals (NIH/PubMed — Lobraico JM, 2015).
• Helps knee comfort in osteoarthritis* — 6-month RCT showed modest improvements in pain/function (NIH/PubMed — Kuszewski JC, 2022).
• Relieves dry eye symptoms* — Trial showed improvements in DED measures with krill-oil omega-3s (NIH/PubMed — Deinema LA, 2017).
• Supports cognitive function (older adults)* — Working-memory measures improved vs sardine oil (NIH/PMC — Konagai C, 2013).
• Supports cognitive measures in adolescents* — 1-year trial evaluated attention/memory outcomes (NIH/PubMed — Van der Wurff ISM, 2019).
• Helps with PMS symptom relief* — NKO® reduced dysmenorrhea and emotional PMS vs fish oil (NIH/PubMed — Sampalis F, 2003).
• Supports omega-3 bioavailability* — Phospholipid EPA/DHA enhanced plasma/RBC incorporation (NIH/PMC — Schuchardt JP, 2015).

• Lipid management overview* — Reviews discuss TG and lipid outcomes; more CVD endpoints needed (NIH/PubMed — Cicero AFG, 2023).
• Dry eye meta-signals* — Omega-3s show symptom benefits in subsets; heterogeneity noted (NIH/PMC — Bhargava R, 2023).
• Knee OA (mixed findings)* — 24-week RCT reported no superiority vs placebo for knee pain (NIH/PubMed — Kuszewski JC, 2024).
• Lipidomic partitioning* — Distinct plasma lipidomic profiles vs fish oil (NIH/PubMed — Ramprasath VR, 2020).
• Comparative TG-lowering* — Krill PL vs ethyl esters explored TG/inflammation markers (NIH/PMC — Ulven SM, 2016).
• CVD risk overview* — Narrative review on omega-3 index and lipids (NIH/PMC — Ulven SM, 2014).

• University of Oslo — Investigates omega-3 phospholipid bioavailability.
• Johns Hopkins — Explores lipid management and joint health outcomes.

• World Health Organization (WHO) — Provides guidance on omega-3 intake within heart-healthy dietary patterns.

Neptune Krill Oil (NKO®) — Antarctic krill oil delivering EPA & DHA predominantly in phospholipid form plus astaxanthin (NIH/PMC — Schuchardt JP, 2015)(NIH/PubMed — Ulven SM, 2015).

• Helps lower fasting triglycerides*
• Supports endothelial function & HDL in T2D*
• May ease mild–moderate knee OA symptoms*
• Supports dry eye comfort & tear stability*
• Phospholipid-bound EPA/DHA plus astaxanthin*
• 3rd-party lab tested for purity & potency

See product label for use instructions or as directed by your healthcare professional.*

• Serving Size — 2 softgels (1,000 mg krill oil)
• Servings Per Container — 30
• Ingredient Source — NKO® (Aker BioMarine Antarctic krill)
• Form — Softgel
• Free From — Non-GMO, gluten-free*
• Quality — Third-party tested for identity, potency & purity

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Neptune Krill Oil (NKO®) — 1,000 mg supports triglyceride management, joint comfort, dry eye relief & cognitive health. Non-GMO, 3rd-party tested. Clinically Studied Ingredients — NIH/PubMed!*